BetterLife Pharma Inc. (FRA:NPAU)

Germany flag Germany · Delayed Price · Currency is EUR
0.0330
+0.0050 (17.86%)
Last updated: Dec 5, 2025, 8:06 AM CET
-54.79%
Market Cap 6.23M
Revenue (ttm) n/a
Net Income (ttm) -530.57K
Shares Out n/a
EPS (ttm) -0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume 1,661
Open 0.0330
Previous Close 0.0280
Day's Range 0.0330 - 0.0330
52-Week Range 0.0215 - 0.0935
Beta n/a
RSI 48.24
Earnings Date Dec 29, 2025

About BetterLife Pharma

BetterLife Pharma Inc., a biotechnology company, primarily focuses on developing compounds for the treatment of mental disorders in Canada. It is also involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight viral infections. The company’s products pipeline includes BETR-001 for the treatment of major depressive disorder, anxiety disorder, and neuropathic pain and other neuro-psychiatric and neurological disorders; and BETR-002 to t... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2002
Employees 7
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol NPAU
Full Company Profile

Financial Performance

Financial numbers in CAD Financial Statements

News

There is no news available yet.